Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Nuvo Pharmaceuticals Inc
MRVFF
Healthcare
Drug Manufacturers - Specialty & Generic
Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.
ts.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCQX:MRVFF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Next
(304)
•••
beenthere
X
View Profile
View Bullboard History
Comment by
beenthere
on Jun 30, 2019 8:00pm
RE:Nuvo Research Inc
Ha! Ha! Ha! I got you beat by a country mile!! lol I bought my first 1000 shares in March 2000 for $12.50! And they did one reverse split if I remember correctly at 62 to 1! You do the math! After
...more
(74)
•••
Itdontmatter
X
View Profile
View Bullboard History
Post by
Itdontmatter
on Jun 23, 2019 8:07pm
Nuvo Research Inc
July, 2016 this was a $7.00 stock.
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(0)
•••
runmyownlife
X
View Profile
View Bullboard History
Post by
runmyownlife
on Jun 18, 2019 3:40pm
Competence
When negotiating debt with Deerfield a few months ago and knowing the source of funding to repay the debt was subject to risk (court case), would not a competent manager structure a contingency at the
...more
(1)
•••
ValueCap
X
View Profile
View Bullboard History
Post by
ValueCap
on Jun 18, 2019 10:47am
Bloom Burton Raises Valuation Model
Keeps target the same at 2.50 until synergies start to be realized without impacting topline https://www.bloomburton.com/research/NRI20190618.pdf
(1)
•••
ValueCap
X
View Profile
View Bullboard History
Post by
ValueCap
on Jun 17, 2019 5:00pm
Certainly no bankruptcy. And some more good news
Cost synergies to save 7 million. Blexten growing at 72% over last year in high allergy season. Cambia up 33%. Deerfield allowing for deferral mechanism at Nuvo’s discretion if Vimovo US loses
...more
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Jun 17, 2019 8:19am
Synergies
$7 million in annual savings => $0.12 eps....... “Nuvo has identified synergies within the combined business and is making organizational changes that the Company believes will reduce its
...more
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 12, 2019 2:54pm
RE:RE:RE:RE:Oh how the mighty have fallen...
Get frigging real. PLI was not generating positive cash flow, NRI is.......
(74)
•••
consultant99
X
View Profile
View Bullboard History
Comment by
consultant99
on Jun 10, 2019 6:20pm
RE:RE:Oh how the mighty have fallen...
Bankrupcy? Perhaps but ultimately if the loan is not repaid the leader converts to shares and there is massive dilution. Ultimately shareholders get the same treatment - pennies on the dollar. This
...more
(1)
•••
ValueCap
X
View Profile
View Bullboard History
Comment by
ValueCap
on Jun 06, 2019 6:07pm
RE:Oh how the mighty have fallen...
Thats all great history, but the question is, is there value here at this price? If these guys arent going bankrupt - which doesnt make sense with the current business - then there at least is some
...more
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 06, 2019 4:12pm
RE:Notice Of annual Meeting of Share -- Compensation
Vote against all the compensation proposals and the whole damn board.....
(35)
•••
Spuds21
X
View Profile
View Bullboard History
Post by
Spuds21
on Jun 06, 2019 2:51pm
Notice Of annual Meeting of Share -- Compensation
Really - Read the Notice - All about compensation... for what exactly? Election of directors? Base Salary ? Maternity Leave ? The company share price has been destroyed...
...more
(74)
•••
consultant99
X
View Profile
View Bullboard History
Post by
consultant99
on Jun 06, 2019 1:20pm
Oh how the mighty have fallen...
$1 invested in Nuvo at the time of the spin-off vote is now worth $0.21 Nuvo which held the profitable Pennsaid franchise is now worth 43% of the value remaining. Bloom Burton was favourable to the
...more
(1)
•••
ValueCap
X
View Profile
View Bullboard History
Comment by
ValueCap
on May 31, 2019 5:33pm
RE:RE:Market Cap hit 6.6 Million today
12 month target 2.50. $.70 to 2.50... there’s a return. https://www.bloomburton.com/research/NRI20190516.pdf
(1)
•••
Marathon11
X
View Profile
View Bullboard History
Comment by
Marathon11
on May 31, 2019 2:02pm
RE:Market Cap hit 6.6 Million today
You are correct. Based on what we know, this is hugely oversold. Definitely some serious manipulation to accumulate in my opinion. What was Bloom Burton's revised 12 month target?
(0)
•••
runmyownlife
X
View Profile
View Bullboard History
Comment by
runmyownlife
on May 31, 2019 1:45pm
RE:Market Cap hit 6.6 Million today
Not wrong. Perhaps optimistic that management can execute on sales (historical a huge competency gap) to maintain current levels. And optimistic that management can manage expenses (also a competency
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden